nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Gadobenate Dimeglumine—ALB—multiple sclerosis	0.0157	0.5	CrCbGaD
Gadodiamide—Gadofosveset trisodium—ALB—multiple sclerosis	0.0157	0.5	CrCbGaD
Gadodiamide—Diarrhoea—Azathioprine—multiple sclerosis	0.00178	0.00184	CcSEcCtD
Gadodiamide—Discomfort—Prednisolone—multiple sclerosis	0.00178	0.00183	CcSEcCtD
Gadodiamide—Hallucination—Prednisone—multiple sclerosis	0.00175	0.00181	CcSEcCtD
Gadodiamide—Malaise—Triamcinolone—multiple sclerosis	0.00175	0.00181	CcSEcCtD
Gadodiamide—Malaise—Methylprednisolone—multiple sclerosis	0.00175	0.0018	CcSEcCtD
Gadodiamide—Syncope—Triamcinolone—multiple sclerosis	0.00174	0.0018	CcSEcCtD
Gadodiamide—Syncope—Methylprednisolone—multiple sclerosis	0.00174	0.00179	CcSEcCtD
Gadodiamide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00173	0.00179	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00172	0.00178	CcSEcCtD
Gadodiamide—Oedema—Prednisolone—multiple sclerosis	0.00172	0.00178	CcSEcCtD
Gadodiamide—Dizziness—Azathioprine—multiple sclerosis	0.00172	0.00177	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00172	0.00177	CcSEcCtD
Gadodiamide—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00171	0.00176	CcSEcCtD
Gadodiamide—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.0017	0.00176	CcSEcCtD
Gadodiamide—Shock—Prednisolone—multiple sclerosis	0.0017	0.00175	CcSEcCtD
Gadodiamide—Convulsion—Triamcinolone—multiple sclerosis	0.00168	0.00174	CcSEcCtD
Gadodiamide—Tachycardia—Prednisolone—multiple sclerosis	0.00168	0.00174	CcSEcCtD
Gadodiamide—Convulsion—Methylprednisolone—multiple sclerosis	0.00168	0.00173	CcSEcCtD
Gadodiamide—Urticaria—Mitoxantrone—multiple sclerosis	0.00167	0.00172	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00167	0.00172	CcSEcCtD
Gadodiamide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00166	0.00171	CcSEcCtD
Gadodiamide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00166	0.00171	CcSEcCtD
Gadodiamide—Myalgia—Triamcinolone—multiple sclerosis	0.00165	0.00171	CcSEcCtD
Gadodiamide—Vomiting—Azathioprine—multiple sclerosis	0.00165	0.00171	CcSEcCtD
Gadodiamide—Myalgia—Methylprednisolone—multiple sclerosis	0.00165	0.0017	CcSEcCtD
Gadodiamide—Arthralgia—Methylprednisolone—multiple sclerosis	0.00165	0.0017	CcSEcCtD
Gadodiamide—Anxiety—Methylprednisolone—multiple sclerosis	0.00164	0.0017	CcSEcCtD
Gadodiamide—Rash—Azathioprine—multiple sclerosis	0.00164	0.00169	CcSEcCtD
Gadodiamide—Dermatitis—Azathioprine—multiple sclerosis	0.00164	0.00169	CcSEcCtD
Gadodiamide—Flushing—Prednisone—multiple sclerosis	0.00164	0.00169	CcSEcCtD
Gadodiamide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00163	0.00169	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00163	0.00169	CcSEcCtD
Gadodiamide—Discomfort—Triamcinolone—multiple sclerosis	0.00163	0.00169	CcSEcCtD
Gadodiamide—Discomfort—Methylprednisolone—multiple sclerosis	0.00163	0.00168	CcSEcCtD
Gadodiamide—Headache—Azathioprine—multiple sclerosis	0.00163	0.00168	CcSEcCtD
Gadodiamide—Dry mouth—Triamcinolone—multiple sclerosis	0.00162	0.00167	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—multiple sclerosis	0.00161	0.00166	CcSEcCtD
Gadodiamide—Malaise—Dexamethasone—multiple sclerosis	0.00159	0.00164	CcSEcCtD
Gadodiamide—Malaise—Betamethasone—multiple sclerosis	0.00159	0.00164	CcSEcCtD
Gadodiamide—Oedema—Triamcinolone—multiple sclerosis	0.00158	0.00164	CcSEcCtD
Gadodiamide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00158	0.00164	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00158	0.00163	CcSEcCtD
Gadodiamide—Syncope—Dexamethasone—multiple sclerosis	0.00158	0.00163	CcSEcCtD
Gadodiamide—Syncope—Betamethasone—multiple sclerosis	0.00158	0.00163	CcSEcCtD
Gadodiamide—Arrhythmia—Prednisone—multiple sclerosis	0.00157	0.00163	CcSEcCtD
Gadodiamide—Infection—Triamcinolone—multiple sclerosis	0.00157	0.00163	CcSEcCtD
Gadodiamide—Infection—Methylprednisolone—multiple sclerosis	0.00157	0.00162	CcSEcCtD
Gadodiamide—Shock—Triamcinolone—multiple sclerosis	0.00156	0.00161	CcSEcCtD
Gadodiamide—Shock—Methylprednisolone—multiple sclerosis	0.00156	0.00161	CcSEcCtD
Gadodiamide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Gadodiamide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Gadodiamide—Loss of consciousness—Betamethasone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Gadodiamide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisolone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Gadodiamide—Tachycardia—Triamcinolone—multiple sclerosis	0.00155	0.0016	CcSEcCtD
Gadodiamide—Nausea—Azathioprine—multiple sclerosis	0.00154	0.00159	CcSEcCtD
Gadodiamide—Tachycardia—Methylprednisolone—multiple sclerosis	0.00154	0.00159	CcSEcCtD
Gadodiamide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00153	0.00158	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00153	0.00158	CcSEcCtD
Gadodiamide—Convulsion—Dexamethasone—multiple sclerosis	0.00153	0.00158	CcSEcCtD
Gadodiamide—Convulsion—Betamethasone—multiple sclerosis	0.00153	0.00158	CcSEcCtD
Gadodiamide—Asthenia—Mitoxantrone—multiple sclerosis	0.00151	0.00156	CcSEcCtD
Gadodiamide—Myalgia—Dexamethasone—multiple sclerosis	0.0015	0.00155	CcSEcCtD
Gadodiamide—Myalgia—Betamethasone—multiple sclerosis	0.0015	0.00155	CcSEcCtD
Gadodiamide—Anxiety—Betamethasone—multiple sclerosis	0.00149	0.00154	CcSEcCtD
Gadodiamide—Anxiety—Dexamethasone—multiple sclerosis	0.00149	0.00154	CcSEcCtD
Gadodiamide—Discomfort—Dexamethasone—multiple sclerosis	0.00148	0.00153	CcSEcCtD
Gadodiamide—Discomfort—Betamethasone—multiple sclerosis	0.00148	0.00153	CcSEcCtD
Gadodiamide—Hypotension—Methylprednisolone—multiple sclerosis	0.00148	0.00153	CcSEcCtD
Gadodiamide—Pain—Prednisolone—multiple sclerosis	0.00147	0.00152	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—multiple sclerosis	0.00146	0.00151	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00145	0.0015	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—multiple sclerosis	0.00144	0.00149	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00144	0.00149	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00144	0.00149	CcSEcCtD
Gadodiamide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00144	0.00148	CcSEcCtD
Gadodiamide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00144	0.00148	CcSEcCtD
Gadodiamide—Oedema—Dexamethasone—multiple sclerosis	0.00144	0.00148	CcSEcCtD
Gadodiamide—Oedema—Betamethasone—multiple sclerosis	0.00144	0.00148	CcSEcCtD
Gadodiamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00144	0.00148	CcSEcCtD
Gadodiamide—Infection—Betamethasone—multiple sclerosis	0.00143	0.00147	CcSEcCtD
Gadodiamide—Infection—Dexamethasone—multiple sclerosis	0.00143	0.00147	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Gadodiamide—Paraesthesia—Triamcinolone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisolone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Gadodiamide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—multiple sclerosis	0.00142	0.00147	CcSEcCtD
Gadodiamide—Shock—Dexamethasone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Gadodiamide—Shock—Betamethasone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Gadodiamide—Dyspnoea—Triamcinolone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Gadodiamide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Gadodiamide—Nervous system disorder—Betamethasone—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Gadodiamide—Tachycardia—Dexamethasone—multiple sclerosis	0.0014	0.00145	CcSEcCtD
Gadodiamide—Tachycardia—Betamethasone—multiple sclerosis	0.0014	0.00145	CcSEcCtD
Gadodiamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.00139	0.00144	CcSEcCtD
Gadodiamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00139	0.00144	CcSEcCtD
Gadodiamide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00139	0.00143	CcSEcCtD
Gadodiamide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00139	0.00143	CcSEcCtD
Gadodiamide—Malaise—Prednisone—multiple sclerosis	0.00138	0.00143	CcSEcCtD
Gadodiamide—Syncope—Prednisone—multiple sclerosis	0.00138	0.00142	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—multiple sclerosis	0.00137	0.00142	CcSEcCtD
Gadodiamide—Urticaria—Prednisolone—multiple sclerosis	0.00137	0.00141	CcSEcCtD
Gadodiamide—Fatigue—Triamcinolone—multiple sclerosis	0.00137	0.00141	CcSEcCtD
Gadodiamide—Fatigue—Methylprednisolone—multiple sclerosis	0.00136	0.00141	CcSEcCtD
Gadodiamide—Pain—Triamcinolone—multiple sclerosis	0.00136	0.0014	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisone—multiple sclerosis	0.00135	0.00139	CcSEcCtD
Gadodiamide—Hypotension—Dexamethasone—multiple sclerosis	0.00134	0.00139	CcSEcCtD
Gadodiamide—Hypotension—Betamethasone—multiple sclerosis	0.00134	0.00139	CcSEcCtD
Gadodiamide—Vomiting—Mitoxantrone—multiple sclerosis	0.00134	0.00138	CcSEcCtD
Gadodiamide—Convulsion—Prednisone—multiple sclerosis	0.00133	0.00137	CcSEcCtD
Gadodiamide—Rash—Mitoxantrone—multiple sclerosis	0.00132	0.00137	CcSEcCtD
Gadodiamide—Dermatitis—Mitoxantrone—multiple sclerosis	0.00132	0.00137	CcSEcCtD
Gadodiamide—Chills—Methotrexate—multiple sclerosis	0.00132	0.00136	CcSEcCtD
Gadodiamide—Headache—Mitoxantrone—multiple sclerosis	0.00132	0.00136	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00131	0.00135	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00131	0.00135	CcSEcCtD
Gadodiamide—Arthralgia—Prednisone—multiple sclerosis	0.00131	0.00135	CcSEcCtD
Gadodiamide—Myalgia—Prednisone—multiple sclerosis	0.00131	0.00135	CcSEcCtD
Gadodiamide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00131	0.00135	CcSEcCtD
Gadodiamide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0013	0.00134	CcSEcCtD
Gadodiamide—Anxiety—Prednisone—multiple sclerosis	0.0013	0.00134	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00129	0.00133	CcSEcCtD
Gadodiamide—Paraesthesia—Betamethasone—multiple sclerosis	0.00129	0.00133	CcSEcCtD
Gadodiamide—Paraesthesia—Dexamethasone—multiple sclerosis	0.00129	0.00133	CcSEcCtD
Gadodiamide—Discomfort—Prednisone—multiple sclerosis	0.00129	0.00133	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisolone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Gadodiamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Gadodiamide—Dyspepsia—Betamethasone—multiple sclerosis	0.00127	0.00131	CcSEcCtD
Gadodiamide—Urticaria—Triamcinolone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Gadodiamide—Urticaria—Methylprednisolone—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—multiple sclerosis	0.00126	0.0013	CcSEcCtD
Gadodiamide—Body temperature increased—Triamcinolone—multiple sclerosis	0.00125	0.00129	CcSEcCtD
Gadodiamide—Oedema—Prednisone—multiple sclerosis	0.00125	0.00129	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisone—multiple sclerosis	0.00125	0.00129	CcSEcCtD
Gadodiamide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00125	0.00129	CcSEcCtD
Gadodiamide—Nausea—Mitoxantrone—multiple sclerosis	0.00125	0.00129	CcSEcCtD
Gadodiamide—Infection—Prednisone—multiple sclerosis	0.00124	0.00128	CcSEcCtD
Gadodiamide—Fatigue—Betamethasone—multiple sclerosis	0.00124	0.00128	CcSEcCtD
Gadodiamide—Fatigue—Dexamethasone—multiple sclerosis	0.00124	0.00128	CcSEcCtD
Gadodiamide—Shock—Prednisone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Gadodiamide—Pain—Betamethasone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Gadodiamide—Pain—Dexamethasone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Gadodiamide—Nervous system disorder—Prednisone—multiple sclerosis	0.00123	0.00127	CcSEcCtD
Gadodiamide—Tachycardia—Prednisone—multiple sclerosis	0.00122	0.00126	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisone—multiple sclerosis	0.00121	0.00125	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00119	0.00123	CcSEcCtD
Gadodiamide—Feeling abnormal—Betamethasone—multiple sclerosis	0.00118	0.00122	CcSEcCtD
Gadodiamide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00118	0.00122	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00118	0.00121	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00118	0.00121	CcSEcCtD
Gadodiamide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00117	0.00121	CcSEcCtD
Gadodiamide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00116	0.0012	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—multiple sclerosis	0.00116	0.00119	CcSEcCtD
Gadodiamide—Urticaria—Betamethasone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Gadodiamide—Urticaria—Dexamethasone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Gadodiamide—Dizziness—Prednisolone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Gadodiamide—Asthenia—Triamcinolone—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Gadodiamide—Body temperature increased—Betamethasone—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Gadodiamide—Body temperature increased—Dexamethasone—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Gadodiamide—Abdominal pain—Betamethasone—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Gadodiamide—Abdominal pain—Dexamethasone—multiple sclerosis	0.00114	0.00117	CcSEcCtD
Gadodiamide—Asthenia—Methylprednisolone—multiple sclerosis	0.00113	0.00117	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisone—multiple sclerosis	0.00112	0.00116	CcSEcCtD
Gadodiamide—Pruritus—Triamcinolone—multiple sclerosis	0.00112	0.00116	CcSEcCtD
Gadodiamide—Pruritus—Methylprednisolone—multiple sclerosis	0.00112	0.00115	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—multiple sclerosis	0.00111	0.00115	CcSEcCtD
Gadodiamide—Dyspepsia—Prednisone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Gadodiamide—Rash—Prednisolone—multiple sclerosis	0.00109	0.00112	CcSEcCtD
Gadodiamide—Dermatitis—Prednisolone—multiple sclerosis	0.00109	0.00112	CcSEcCtD
Gadodiamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00108	0.00112	CcSEcCtD
Gadodiamide—Fatigue—Prednisone—multiple sclerosis	0.00108	0.00111	CcSEcCtD
Gadodiamide—Headache—Prednisolone—multiple sclerosis	0.00108	0.00111	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—multiple sclerosis	0.00108	0.00111	CcSEcCtD
Gadodiamide—Dizziness—Triamcinolone—multiple sclerosis	0.00105	0.00108	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00105	0.00108	CcSEcCtD
Gadodiamide—Dizziness—Methylprednisolone—multiple sclerosis	0.00105	0.00108	CcSEcCtD
Gadodiamide—Infection—Methotrexate—multiple sclerosis	0.00104	0.00107	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Gadodiamide—Asthenia—Betamethasone—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Gadodiamide—Asthenia—Dexamethasone—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—multiple sclerosis	0.00103	0.00106	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00102	0.00106	CcSEcCtD
Gadodiamide—Nausea—Prednisolone—multiple sclerosis	0.00102	0.00106	CcSEcCtD
Gadodiamide—Pruritus—Dexamethasone—multiple sclerosis	0.00102	0.00105	CcSEcCtD
Gadodiamide—Pruritus—Betamethasone—multiple sclerosis	0.00102	0.00105	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Gadodiamide—Vomiting—Triamcinolone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Gadodiamide—Vomiting—Methylprednisolone—multiple sclerosis	0.00101	0.00104	CcSEcCtD
Gadodiamide—Rash—Triamcinolone—multiple sclerosis	0.000999	0.00103	CcSEcCtD
Gadodiamide—Dermatitis—Triamcinolone—multiple sclerosis	0.000998	0.00103	CcSEcCtD
Gadodiamide—Rash—Methylprednisolone—multiple sclerosis	0.000997	0.00103	CcSEcCtD
Gadodiamide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000996	0.00103	CcSEcCtD
Gadodiamide—Urticaria—Prednisone—multiple sclerosis	0.000995	0.00103	CcSEcCtD
Gadodiamide—Headache—Triamcinolone—multiple sclerosis	0.000993	0.00102	CcSEcCtD
Gadodiamide—Headache—Methylprednisolone—multiple sclerosis	0.00099	0.00102	CcSEcCtD
Gadodiamide—Body temperature increased—Prednisone—multiple sclerosis	0.00099	0.00102	CcSEcCtD
Gadodiamide—Abdominal pain—Prednisone—multiple sclerosis	0.00099	0.00102	CcSEcCtD
Gadodiamide—Diarrhoea—Betamethasone—multiple sclerosis	0.000984	0.00102	CcSEcCtD
Gadodiamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000984	0.00102	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—multiple sclerosis	0.000978	0.00101	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000953	0.000984	CcSEcCtD
Gadodiamide—Dizziness—Dexamethasone—multiple sclerosis	0.000951	0.000982	CcSEcCtD
Gadodiamide—Dizziness—Betamethasone—multiple sclerosis	0.000951	0.000982	CcSEcCtD
Gadodiamide—Nausea—Triamcinolone—multiple sclerosis	0.000941	0.000972	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—multiple sclerosis	0.00094	0.00097	CcSEcCtD
Gadodiamide—Nausea—Methylprednisolone—multiple sclerosis	0.000939	0.000969	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—multiple sclerosis	0.000933	0.000963	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—multiple sclerosis	0.00093	0.00096	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisone—multiple sclerosis	0.000923	0.000952	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000921	0.000951	CcSEcCtD
Gadodiamide—Vomiting—Betamethasone—multiple sclerosis	0.000914	0.000944	CcSEcCtD
Gadodiamide—Vomiting—Dexamethasone—multiple sclerosis	0.000914	0.000944	CcSEcCtD
Gadodiamide—Rash—Betamethasone—multiple sclerosis	0.000907	0.000936	CcSEcCtD
Gadodiamide—Rash—Dexamethasone—multiple sclerosis	0.000907	0.000936	CcSEcCtD
Gadodiamide—Dermatitis—Betamethasone—multiple sclerosis	0.000906	0.000935	CcSEcCtD
Gadodiamide—Dermatitis—Dexamethasone—multiple sclerosis	0.000906	0.000935	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—multiple sclerosis	0.000902	0.000931	CcSEcCtD
Gadodiamide—Headache—Dexamethasone—multiple sclerosis	0.000901	0.00093	CcSEcCtD
Gadodiamide—Headache—Betamethasone—multiple sclerosis	0.000901	0.00093	CcSEcCtD
Gadodiamide—Asthenia—Prednisone—multiple sclerosis	0.000898	0.000927	CcSEcCtD
Gadodiamide—Pain—Methotrexate—multiple sclerosis	0.000895	0.000924	CcSEcCtD
Gadodiamide—Pruritus—Prednisone—multiple sclerosis	0.000886	0.000915	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000862	0.00089	CcSEcCtD
Gadodiamide—Diarrhoea—Prednisone—multiple sclerosis	0.000857	0.000884	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000856	0.000883	CcSEcCtD
Gadodiamide—Nausea—Dexamethasone—multiple sclerosis	0.000854	0.000882	CcSEcCtD
Gadodiamide—Nausea—Betamethasone—multiple sclerosis	0.000854	0.000882	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—multiple sclerosis	0.000831	0.000858	CcSEcCtD
Gadodiamide—Dizziness—Prednisone—multiple sclerosis	0.000828	0.000855	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—multiple sclerosis	0.000827	0.000854	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—multiple sclerosis	0.000827	0.000854	CcSEcCtD
Gadodiamide—Vomiting—Prednisone—multiple sclerosis	0.000796	0.000822	CcSEcCtD
Gadodiamide—Rash—Prednisone—multiple sclerosis	0.000789	0.000815	CcSEcCtD
Gadodiamide—Dermatitis—Prednisone—multiple sclerosis	0.000789	0.000814	CcSEcCtD
Gadodiamide—Headache—Prednisone—multiple sclerosis	0.000784	0.00081	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000771	0.000796	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—multiple sclerosis	0.000751	0.000775	CcSEcCtD
Gadodiamide—Nausea—Prednisone—multiple sclerosis	0.000744	0.000768	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—multiple sclerosis	0.00074	0.000764	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—multiple sclerosis	0.000716	0.000739	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—multiple sclerosis	0.000692	0.000714	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—multiple sclerosis	0.000665	0.000687	CcSEcCtD
Gadodiamide—Rash—Methotrexate—multiple sclerosis	0.00066	0.000681	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—multiple sclerosis	0.000659	0.00068	CcSEcCtD
Gadodiamide—Headache—Methotrexate—multiple sclerosis	0.000656	0.000677	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—multiple sclerosis	0.000622	0.000642	CcSEcCtD
